Immune memory and immune response in children from bulgaria 5-15 years after primary hepatitis B vaccination

Pediatric Infectious Disease Journal

Volumn 32, Issue 1, 2013, Pages 51-53

  Teoharov, Pavel ^a   Kevorkyan, Ani ^b   Petrova, Nedyalka ^b   Baltadzhiev, Ivan ^b   Van Damme, Pierre ^c  

^a NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^b MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

5 15 year follow up; hepatitis B vaccine; immune memory; immune response

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BULGARIA; CHILD; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT OUTCOME; VACCINATION; VIRUS IMMUNITY;

ADOLESCENT; BULGARIA; CHILD; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; MALE; STATISTICS, NONPARAMETRIC;

EID: 84871791414     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31826f354e     Document Type: Article

References (15)

1. Gatcheva N, Vladimirova N, Kourtchatova A. Implementing universal vaccination programmes: Bulgaria. Vaccine. 1995;13(suppl 1):S82-S83.
2. Kojouharova M, Teoharov P, Bahtchevanova T, et al. Safety and immunogenicity of a yeast-derived recombinant hepatitis B vaccine in Bulgarian newborns. Infection. 2001;29:342-344. (Pubitemid 33151357)
3. Watson B, West DJ, Chilkatowsky A, et al. Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine. Vaccine. 2001;19:3164-3168. (Pubitemid 32324045)
4. Van Damme P, Van Herck K. A review of the long-term protection after hepatitis A and B vaccination. Travel Med Infect Dis. 2007;5:79-84. (Pubitemid 46211211)
5. McMahon BJ, Bruden DL, Petersen KM, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med. 2005;142:333-341. (Pubitemid 40293406)
6. Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53:68-75.
7. Petersen KM, Bulkow LR, McMahon BJ, et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J. 2004;23:650-655. (Pubitemid 38924890)
8. van der Sande MA, Waight P, Mendy M, et al. Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis. 2006;193:1528-1535. (Pubitemid 43794582)
9. Petrunov B, Kojouharova M, Teoharov P, et al. EU project Interreg II: seroepidemiology study on hepatitis B and C viral infection prevalence in Bulgaria and northern Greece. J Hepatol. 2002; 36(suppl 1):138-139.
10. Williams IT, Goldstein ST, Tufa J, et al. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J. 2003;22:157-163. (Pubitemid 36228133)
11. Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine. 2000;19:877-885.
12. European Consensus Group on Hepatitis B Immunity. Are booster immunization needed for lifelong hepatitis B immunity? Lancet. 2000;355:561-565.
13. Fitzsimons D, François G, Hall A, et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine. 2005;23:4158-4166. (Pubitemid 40814591)
14. Centers for Disease Control and Prevention. Hepatitis B vaccination recommendation for infants, children and adolescents. MMWR Morb Mortal Wkly Rep. 2005;54(RR16):27-30
15. World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec. 2009;40:405-42.